Left ventricular concentric geometry is associated with impaired relaxation in hypertension: the HyperGEN study

Giovanni de Simone1, Dalane W Kitzman, Marcello Chinali

  • 1Weill Medical College of Cornell University, New York, NY, USA. simogi@unina.it

European Heart Journal
|December 25, 2004
PubMed

Insights

Abnormal left ventricular (LV) relaxation is linked to concentric LV geometry in hypertensive individuals. This finding highlights the importance of assessing LV geometry for understanding relaxation abnormalities.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology
  • Echocardiography

Background:

  • Hypertension is a major risk factor for cardiovascular disease.
  • Left ventricular (LV) geometry and relaxation are key indicators of cardiac health.
  • Understanding the relationship between LV geometry and relaxation is crucial for early detection and management of cardiovascular complications.

Purpose of the Study:

  • To investigate the association between abnormal left ventricular (LV) relaxation and concentric LV geometry.
  • To determine if LV hypertrophy influences this relationship.

Main Methods:

  • Doppler echocardiography was used to assess LV filling properties in 1384 hypertensive participants.
  • Participants were categorized into four LV geometry groups: normal, concentric remodeling, eccentric, and concentric LV hypertrophy.
  • Abnormal LV relaxation was identified using European Society of Cardiology criteria.

Main Results:

  • Delayed LV relaxation was significantly associated with concentric LV geometry (P<0.0001).
  • While LV hypertrophy prolonged deceleration time, the relationship with concentric geometry differed based on hypertrophy presence.
  • Concentric LV geometry increased the odds of abnormal LV relaxation by 2.3-fold.

Conclusions:

  • Delayed LV relaxation is independently associated with concentric LV geometry in hypertensive individuals without cardiovascular disease.
  • These findings suggest that concentric LV geometry is a significant predictor of abnormal LV relaxation.
Abstract

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...